Elsevier

Brain Stimulation

Volume 10, Issue 3, May–June 2017, Pages 714-715
Brain Stimulation

Antidepressant remission to dTMS of the dmPFC and ACC in lateral PFC dTMS nonresponders: Case series

https://doi.org/10.1016/j.brs.2017.01.579Get rights and content

Highlights

  • •

    Patients who failed H1 dTMS to the L DLPFC were administered H7 dTMS to the dmPFC and ACC resulting in 56% remission.

  • •

    Suggesting that some depression patients will get better from deep rTMS to different targets.

  • •

    Future goals include confirming this in a large sample and identifying a priori TMS targeting markers.

Section snippets

Disclosure

Aron Tendler and Abraham Zangen have a financial interest in Brainsway Ltd., the manufacturer of dTMS coils.

Acknowledgements

The authors thank Yiftach Roth PhD and Laura DeLuca MD for their ongoing input, and Brainsway Ltd. for the coil. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Cited by (0)

View full text
© 2017 Elsevier Inc. All rights reserved.